ShareValue.ai

ShareValue scores for 8225.HK: Valuation 48, Quality 34, Growth 62, Health 62.

8225.HK
HKEX

China Health Group Inc

HK$0.10(0.00%)
Loading chart...
Sentiment

Verdicts

Rating

Trap Risk

Return

6% to 17%
Valuation
48
Fair Value
Price vs Value
Quality
34
Weak
Business Strength
Growth
62
Moderate
Revenue & Earnings
Health
62
Moderate
Financial Stability
Momentum
31
Bearish
Price Trend

Company Details

About

China Health Group Inc., together with its subsidiaries, researches and develops bio, natural, and synthetic drugs in the People's Republic of China. It engages in the pharmacodynamics and clinical research of drugs; provision of post market and contracted pharmaceutical development services; and technological transfer and services for the research and development of drugs. The company was formerly known as Venturepharm Laboratories Limited and changed its name to China Health Group Inc. in February 2015. China Health Group Inc. was founded in 1998 and is headquartered in Beijing, China.

Score Analysis

AI Investment Thesis

Data as of:Jul 9, 2026
|
Last calculated:Jul 9, 2026